A Correction to the Research Article Titled: “Amplification of the Driving Oncogene, KRAS or BRAF, Underpins Acquired Resistance to MEK1/2 Inhibitors in Colorectal Cancer Cells” by A. S. Little, K. Balmanno, M. J. Sale, S. Newman, J. R. Dry, M. Hampson, P. A. W. Edwards, P. D. Smith, S. J. Cook

Science Signaling  26 Apr 2011:
Vol. 4, Issue 170, pp. er2
DOI: 10.1126/scisignal.4170er2

See original article:

Log in to view full text

Navigate This Article